Literature DB >> 8762643

Hepatic fascioliasis: case report and review.

S Abdul-Hadi1, R Contreras, C Tombazzi, M Alvarez, M Melendez.   

Abstract

A well documented case of hepatic fascioliasis (HF), successfully treated with triclabendazole, is reported. Predominant clinical manifestations were fever, marked eosinophilia and abdominal pain. Triclabendazole was given as two single oral doses of 10 mg/kg each. Neither side effects nor clinical or parasitological relapses were seen after three months of follow up. Based on this experience and few other similar reports in the literature, triclabendazole might be a valid therapeutical alternative in the treatment of human fascioliasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8762643     DOI: 10.1590/s0036-46651996000100013

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  2 in total

1.  Fascioliasis-a rare cause of hepatic nodules.

Authors:  Helena Temido; Manuel Oliveira-Santos; Francisco Parente; Lèlita Santos
Journal:  BMJ Case Rep       Date:  2017-05-31

2.  A new baseline for fascioliasis in Venezuela: lymnaeid vectors ascertained by DNA sequencing and analysis of their relationships with human and animal infection.

Authors:  M Dolores Bargues; L Carolina González; Patricio Artigas; Santiago Mas-Coma
Journal:  Parasit Vectors       Date:  2011-10-14       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.